Effects of defibrotide on leukocyte-endothelial cell interaction in the rat mesenteric vascular bed: Role of P-selectin

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 18, Issue 10, 1996, Pages 669-676

  Scalia, Rosario ^a   Kochilas, Lazaros ^a   Campbell, Barry ^a   Lefer, Allan M ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

defibrotide; intravital microscopy; leukocyte adherence; leukocyte rolling; mean arterial blood pressure; venular shear rate

Indexed keywords

DEFIBROTIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PADGEM PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ENDOTHELIUM CELL; IMMUNOHISTOCHEMISTRY; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE; MEAN ARTERIAL PRESSURE; MESENTERY BLOOD FLOW; MICROCIRCULATION; MICROSCOPY; MICROVASCULATURE; NONHUMAN; RAT;

ANIMALS; BLOOD PRESSURE; CELL ADHESION; ENDOTHELIUM, VASCULAR; FIBRINOLYTIC AGENTS; IMMUNOHISTOCHEMISTRY; LEUKOCYTES; MICROCIRCULATION; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; P-SELECTIN; POLYDEOXYRIBONUCLEOTIDES; RATS; RATS, SPRAGUE-DAWLEY; SPLANCHNIC CIRCULATION;

EID: 0030485311     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Masini, E., Lupini, M., Mugnai, L., Raspanti, S., Mannaioni, P.F. Polydeoxyribonucleotides and nitric oxide release from guinea-pig hearts during ischaemia and reperfusion. Br J Pharmacol 1995, 115: 629-34.
2. Scalia, R., Gauthier, T.W., Murohara, T., Lefer, A.M. Oligotide attenuates leukocyte-endothelial cell interaction via P-selectin in the rat mesenteric vascular bed. Eur J Pharmacol 1996, 296: 181-7.
3. Lefer, A.M., Aoki, N., Mulloy, D. Coronary endothelium-protective effects of defibrotide in ischemia and reperfusion. Naunyn-Schmied Arch Pharmacol 1990, 341: 246-50.
4. Niada, R., Pescador, R., Porta, R., Mantovani, M., Prino, G. Defibrotide is antithrombotic and thrombolytic against rabbit venous thrombosis. Haemostasis 1986, 16: 3-8.
5. Palmer, K.J., Goa, K.L. Defibrotide: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in vascular disorders. Drugs 1993, 45: 259-64.
6. 2+-involving mechanism. Int J Tissue React 1987, 9: 399-406.
7. Bittermann, H., Lefer, D.J., Lefer, A.M. Novel mechanism of action of a prostacyclin enhancing agent in hemorrhagic shock. Naunyn-Schmied Arch Pharmacol 1988, 336: 679-89.
8. Thiemermann, C., Lobel, P., Schror, K. Usefulness of defibrotide in protecting ischemic myocardium from early reperfusion damage. Am J Cardiol 1985, 56: 978-82.
9. Fareed, J., Walenga, J.M., Hoppensteadt, D.A., Kumar, A., Ulutin, O.N., Cornelli, U. Pharmacological profiling of defibrotide in experimental models. Semin Thromb Hemost 1991, 14: 27-32.
10. Lorant, D.E., Patel, K.D., McIntyre, T.M., McEver, R.P., Prescott, S.M., Zimmerman, G.A. Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: A juxtacrine system for adhesion and activation of neutrophils. J Cell Biol 1991, 115: 223-34.
11. McEver, R.P., Beckstead, J.H., Moore, K.L., Marshall-Carson, L., Bainton, D.F. GMP-140, a platelet a-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies. J Clin Invest 1989, 84: 92-7.
12. Patel, K.D., Zimmerman, G.A., Prescott, S.M., McEver, R.P., McIntyre, T.M. Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils. J Cell Biol 1991, 112: 749-59.
13. Lorant, D.E., Topham, M.K., Whatley, R.E. et al. Inflammatory roles of P-selectin. J Clin Invest 1993, 92: 559-66.
14. Aoki, N., Johnson, G. III, Lefer, A.M. Beneficial effects of two forms of NO administration in feline splanchnic artery occlusion shock. Am J Physiol 1990, 258: G275-81.
15. Entman, M.L., Michael, L., Rossen, R.D., Dreyer, W.J., Anderson, D.C., Smith, C.W. Inflammation in the course of early myocardial ischemia. FASEB J 1991, 5: 2529-37.
16. Kubes, P., Suzuki, M., Granger, D.N. Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991, 88: 4651-5.
17. Davenpeck, K.L., Gauthier, T.W., Lefer, A.M. Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation. Gastroenterology 1994, 107: 1050-6.
18. Carey, C.M., Siegfried, M.R., Ma, X., Weyrich, A.S., Lefer, A.M. Antishock and endothelial protective action of a NO donor in mesenteric ischemia and reperfusion. Circ Shock 1992, 38: 209-14.
19. Kubes, P., Granger, D.N. Nitric oxide modulates microvascular permeability. Am J Physiol 1992, 262: H611-7.
20. Kurose, I., Kubes, P., Wolf, R. et al. Inhibition of nitric oxide production: Mechanisms of vascular albumin leakage. Circ Res 1993, 73: 164-9.
21. Borders, J.L., Granger, HJ. An optical Doppier intravital velocimeter. Microvasc Res 1984, 27: 117-23.
22. Granger, D.N., Benoit, J.N., Suzuki, M., Grisham, M.B. Leukocyte adherence to venular endothelium during ischemia-reperfusion. Am J Physiol 1989, 257: G683-8.
23. Beckstead, J.H., Stenberg, P.E., McEver, R.P., Shuman, M.C., Bainton, D.F. Immunohistochemical localization of membrane and a-granule proteins in human megakaryocytes: Application to plastic embedded bone marrow biopsy specimens. Blood 1986, 67: 285-93.
24. Weyrich, A.S., Ma, X., Lefer, D.J., Albertine, K.H., Lefer, A.M. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J Clin Invest 1993, 91: 2620-9.
25. Rubanyi, G.M., Vanhoutte, P.M. Oxygen-derived free radicals, endothelial dysfunction and responsiveness of vascular smooth muscle. Am J Physiol 1987, 250: H815-21.
26. Murohara, T., Buerke, M., Lefer, A.M. Polymorphonuclear leukocyte-induced vasocontraction and endothelial dysfunction: Role of selectins. Arterioscler Thromb 1994, 14: 1509-19.
27. Kloner, R.A., Ganote, C.E., Jennings, R.B. The 'no reflow' phenomenon after temporary coronary occlusion in the dog. J Clin Invest 1974, 54: 1496-508.
28. Gauthier, T.W., Davenpeck, K.L., Lefer, A.M. Nitric oxide attenuates leukocyte-endothelial interaction via P-selectin in splanchnic ischemia-reperfusion. Am J Physiol 1994, 267: G562-7.
29. 2-analogues and an NO EDRF-donor: A comparison between platelets of healthy subjects and diabetic subjects. Platelets 1994, 11: 42-8.
30. Bracht, F., Schror, K. Isolation and identification of aptamers from defibrotide that act as thrombin antagonists in vitro. Biochem Biophys Res Commun 1994, 200: 933-7.
31. Ma, X., Weyrich, A.S., Lefer, D.J., Lefer, A.M. Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res 1993, 72: 403-12.
32. Cirillo, F., Margaglione, M., Vecchione, G. et al. In vitro inhibition by defibrotide of monocyte superoxide anion generation: A possible mechanism for the antithrombotic effect of a polydeoxyribonucleotide-derived drug. Haemostasis 1991, 21: 98-105.
33. Lefer, A.M., Lefer, D.J. Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock. Annu Rev Pharmacol Toxicol 1993, 33: 71-90.